Created: 01/31/2014 6:51 PM WDIO.com
By: MATTHEW PERRONE, AP Health Writer
WASHINGTON (AP) - The Food and Drug Administration said Friday it is reviewing the safety of popular testosterone drugs for men in light of recent studies suggesting they can increase the risk of heart attack, stroke and death.
A study published earlier this week suggested testosterone therapy could double the risk of those problems in men older than 65. Another study published in November found that the hormone increased the risk by 30 percent.
The FDA said it is evaluating information from those studies and others but hasn't yet reached any conclusion.
The investigation comes amid an advertising blitz for testosterone gels, patches and injections marketed for low sex drive, fatigue and other age-related ailments in men.
U.S. prescriptions for testosterone have increased more than five-fold in recent years, with sales over $1.6 billion.
Testosterone injections have long been used for men with hypogonadism, a disorder defined by low testosterone caused by injury or infection to the reproductive organs.
But the latest marketing push by drugmakers is for easy-to-use gels and patches that are aimed at a much broader population of otherwise healthy older men with low levels of testosterone, the male hormone that begins to decline in the body after age 40.
Drugmakers and many doctors claim testosterone therapy can reverse some unpleasant of the signs of aging - ranging from insomnia to erectile dysfunction. Those claims are mostly based on short-term studies.
The National Institute on Aging is currently conducting a long-term, 800-man trial to definitively answer whether testosterone therapy improves walking ability, sexual function, energy, memory and blood cell count in men 65 years and older.
Meanwhile the market for testosterone replacements has grown increasingly crowded.
The top-selling product in the field is Abbvie's Androgel, which is applied to the shoulders and arms. Watson Pharmaceuticals markets the Androderm patch, which slowly releases testosterone into the bloodstream. Fortesta is another testosterone gel from Endo Pharmaceuticals, and Eli Lilly's Axiron is an underarm gel that rolls on like deodorant.
(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Alleged Wisc. Bank Robber in St. Louis County Jail
A man was arrested in Duluth Saturday night after he allegedly robbed a bank in Eau Claire, Wisc. the night before. The Eau Claire Police Department responded to a bank robbery at Wells Fargo Bank in Eau Claire on Friday night.
Licenses, Deer Population Down for Wisconsin Deer Opener
The Wisconsin firearm deer hunting tradition got off to a safe start as Department of Natural Resources officials said they had received no reports of accidental shootings or other injuries by mid-afternoon Sunday on the opener of the state's nine-day gun deer hunt.
Northlanders Give Back in Preparation for Holiday Season
Northlanders gave back on Saturday in preparation for the holiday season. It was Family Volunteer Day at the Duluth Library, and folks participated in several friendly projects.
"By Us, For Us" Meeting to Discuss Vision for Equity in Duluth
Duluth's Native and African heritage communities came together on Saturday to share experiences and ideas at the 1st United Methodist Church. The meeting called "By Us, For Us" invited people of color, African Americans and Native Americans to come together to break bread and learn about each other culturally.
MNsure Enrollments, Renewals Approach 8,000
Minnesota's health insurance exchange says it has enrolled nearly 8,000 Minnesotans in health plans in the first week of open enrollment this fall. The deadline for enrolling in coverage that takes effect Jan. 1 is Dec. 15.